Stemness and EMT profiles shift in xenografts derived from cisplatin-sensitive and cisplatin-tolerant ovarian cancer cells

Alena Mrkvicova, Marcela Slavickova, Eva Peterova, Lucie Melounkova, Helena Parova, Radim Havelek, Anna Krejcova, Renata Kohlerova, Jana Nekvindova, Petra Kazimirova, Milena Hajzlerova, Tomáš Rozkoš, Martina Rezacova

Open source

DOI
10.1371/journal.pone.0342326
Published
2026-02-05
Container
PLOS One
Publisher
Public Library of Science (PLoS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0342326,
  title = {Stemness and EMT profiles shift in xenografts derived from cisplatin-sensitive and cisplatin-tolerant ovarian cancer cells},
  author = {Alena Mrkvicova and Marcela Slavickova and Eva Peterova and Lucie Melounkova and Helena Parova and Radim Havelek and Anna Krejcova and Renata Kohlerova and Jana Nekvindova and Petra Kazimirova and Milena Hajzlerova and Tomáš Rozkoš and Martina Rezacova},
  year = {2026},
  journal = {PLOS One},
  doi = {10.1371/journal.pone.0342326},
  url = {https://doi.org/10.1371/journal.pone.0342326}
}

RIS

TY  - JOUR
TI  - Stemness and EMT profiles shift in xenografts derived from cisplatin-sensitive and cisplatin-tolerant ovarian cancer cells
AU  - Alena Mrkvicova
AU  - Marcela Slavickova
AU  - Eva Peterova
AU  - Lucie Melounkova
AU  - Helena Parova
AU  - Radim Havelek
AU  - Anna Krejcova
AU  - Renata Kohlerova
AU  - Jana Nekvindova
AU  - Petra Kazimirova
AU  - Milena Hajzlerova
AU  - Tomáš Rozkoš
AU  - Martina Rezacova
PY  - 2026
JO  - PLOS One
DO  - 10.1371/journal.pone.0342326
UR  - https://doi.org/10.1371/journal.pone.0342326
ER  - 

APA

Mrkvicova, A., Slavickova, M., Peterova, E., Melounkova, L., Parova, H., Havelek, R., Krejcova, A., Kohlerova, R., Nekvindova, J., Kazimirova, P., Hajzlerova, M., Rozkoš, T., & Rezacova, M. (2026). Stemness and EMT profiles shift in xenografts derived from cisplatin-sensitive and cisplatin-tolerant ovarian cancer cells. PLOS One. https://doi.org/10.1371/journal.pone.0342326

Source records